NL
DE
29 November 2019
Host immunity exerts strong selection pressure on viruses, often leading to the evolution of viral mechanisms to evade or suppress the immune response. It is well established that RNA interference (RNAi) is a potent antiviral immune system against RNA viruses. As a counter-defense, RNA viruses often encode proteins that suppress the RNAi response. RNAi also targets DNA viruses, but the antiviral effects seem to be modest.
Using the fruit fly Drosophila melanogaster and a large DNA virus of insects (IIV6) as model system, the research group of Van Rij, including former PhD candidates Walter Bronkhorst and Rob Vogels, has studied the complex interactions between virus and host RNAi. The researchers now show that wildtype IIV6 is indeed mostly insensitive to RNAi, but that an IIV6 mutant lacking its RNAi antagonistic protein becomes extremely sensitive to RNAi. Thus, RNAi is in fact strongly antiviral against DNA viruses, but virus-encoded immune antagonists can fully mask this antiviral activity.
On the photo, from left to right: Ronald van Rij, Gijs Overheul, Pascal Miesen
Host immunity exerts strong selection pressure on viruses, often leading to the evolution of viral mechanisms to evade or suppress the immune response. It is well established that RNA interference (RNAi) is a potent antiviral immune system against RNA viruses. As a counter-defense, RNA viruses often encode proteins that suppress the RNAi response. RNAi also targets DNA viruses, but the antiviral effects seem to be modest.
Using the fruit fly Drosophila melanogaster and a large DNA virus of insects (IIV6) as model system, the research group of Van Rij, including former PhD candidates Walter Bronkhorst and Rob Vogels, has studied the complex interactions between virus and host RNAi. The researchers now show that wildtype IIV6 is indeed mostly insensitive to RNAi, but that an IIV6 mutant lacking its RNAi antagonistic protein becomes extremely sensitive to RNAi. Thus, RNAi is in fact strongly antiviral against DNA viruses, but virus-encoded immune antagonists can fully mask this antiviral activity.
On the photo, from left to right: Ronald van Rij, Gijs Overheul, Pascal Miesen
-
Want to know more about these subjects? Click on the buttons below for more news.
Related news items
Rebecca Halbach receives idea generator grant to fight mosquito transmitted viruses
8 July 2020 Rebecca Halbach and Pascal Miesen have investigated in a collaborative project whether the treatment of mosquitoes with antiviral drugs can prevent the transmission of mosquito-transmitted viral diseases. read more
Invasive fungal infections in influenza and COVID-19
8 July 2020 The Aspergillus fungus is found in the lungs of many COVID patients. A parallel occurs with influenza patients, who often develop a serious fungal infection. Although such a serious fungal infection seems to occur less frequently in COVID-patients, alertness remains necessary, read more
First clinical trial with genetically modified malaria vaccine completed
22 May 2020 In an innovative study, Radboudumc and LUMC jointly tested a candidate vaccine based on a genetically weakened malaria parasite. The results of this clinical trial, published in Science Translational Medicine, show that the vaccine is safe and elicits a defense response against a malaria infection. read more
New step in the development of a vaccine against malaria
22 May 2020 A new vaccine based on rodent malaria parasites achieved a 95% reduction in infection of the liver in humans. An international consortium publishes the results in Science Translational Medicine. read more
Stuttering DNA orchestrates the start of the mosquito’s life
9 April 2020 A certain type of junk DNA that is found in mosquitoes and which repeats itself dozens of times, known as ‘satellite DNA’, has now been shown to play an essential role in the early development of mosquito embryos. Ronald van Rij and colleagues published their findings in Nature. read more
